These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7004444)

  • 21. Participation of both 'enkephalinase' and aminopeptidase activities in the metabolism of endogenous enkephalins.
    de la Baume S; Yi CC; Schwartz JC; Chaillet P; Marcais-Collado H; Costentin J
    Neuroscience; 1983 Jan; 8(1):143-51. PubMed ID: 6300726
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple molecular forms of rat brain enkephalinase.
    Rush RS; Hersh LB
    Life Sci; 1982 Aug; 31(5):445-51. PubMed ID: 6813615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Enkephalinase", a newly characterised dipeptidyl carboxypeptidase: properties and possible role in enkephalinergic transmission.
    Schwartz JC; de la Baume S; Malfroy B; Patey G; Perdrisot R; Swerts JP; Fournie-Zaluski MC; Gacel G; Roques BP
    Int J Neurol; 1980; 14(2-4):195-204. PubMed ID: 6311767
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enkephalin-degrading enzyme inhibitors. Crucial role of the C-terminal residue on the inhibitory potencies of retro-hydroxamate dipeptides.
    Fournié-Zaluski MC; Hernandez JF; Soleilhac JM; Renwart N; Peyroux J; Xie J; Roques BP
    Int J Pept Protein Res; 1989 Feb; 33(2):146-53. PubMed ID: 2707969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of the bidentate inhibitor [3H]HACBO-Gly to the rat brain neutral endopeptidase "enkephalinase".
    Waksman G; Bouboutou R; Devin J; Besselievre R; Fournie-Zaluski MC; Roques BP
    Biochem Biophys Res Commun; 1985 Aug; 131(1):262-8. PubMed ID: 3899113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
    De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
    J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
    Roques BP
    J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of dipeptidyl carboxypeptidase and endopeptidase activities in the three enkephalin-hydrolysing metallopeptidases: "angiotensin-converting enzyme", thermolysin and "enkephalinase".
    Malfroy B; Schwartz JC
    Biochem Biophys Res Commun; 1985 Jul; 130(1):372-8. PubMed ID: 2992465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.
    Dreyer GB; Metcalf BW; Tomaszek TA; Carr TJ; Chandler AC; Hyland L; Fakhoury SA; Magaard VW; Moore ML; Strickler JE
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9752-6. PubMed ID: 2690072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
    Gros C; Noël N; Souque A; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Lecomte JM; Bralet J
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4210-4. PubMed ID: 1851998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
    Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of chronic alcohol consumption on activity of enkephalinase A in rat striatum, hypothalamus and midbrain].
    Beliaev NA; Brusov OS; Panchenko LF
    Vopr Med Khim; 1983; 29(1):102-7. PubMed ID: 6340337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enkephalin degrading enzyme inhibitors: a physiological way to new analgesics and psychoactive agents.
    Roques BP; Fournie-Zaluski MC
    NIDA Res Monogr; 1986; 70():128-54. PubMed ID: 3020420
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neuropeptidases responsible for the inactivation of enkephalins and the pharmacology of their inhibitors].
    Schwartz JC; de la Baume S; Bouthenet ML; Giros B; Gros C; Llorens-Cortes C; Pollard H; Sales N; Solhonne B; Costentin J
    J Pharmacol; 1986; 17 Suppl 2():104-22. PubMed ID: 3546953
    [No Abstract]   [Full Text] [Related]  

  • 37. Enkephalinase activity in both physiological and pathological conditions in man.
    Grazia SM
    Adv Exp Med Biol; 1986; 198 Pt B():161-7. PubMed ID: 3544724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New substrates for enkephalinase (neutral endopeptidase) based on fluorescence energy transfer.
    Malfroy B; Burnier J
    Biochem Biophys Res Commun; 1987 Feb; 143(1):58-66. PubMed ID: 3548727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
    Crawford C; Mason RW; Wikstrom P; Shaw E
    Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.